NCT02195687View on ClinicalTrials.gov

BOTOX® in the Treatment of Crow's Feet Lines in China

PHASE3CompletedINTERVENTIONAL
Enrollment

417

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

June 30, 2015

Conditions
Lateral Canthal LinesCrow's Feet Lines
Interventions
BIOLOGICAL

botulinum toxin Type A

botulinum toxin Type A (BOTOX®) injected into bilateral crow's feet line areas.

DRUG

Normal Saline

Normal Saline (placebo) injected into bilateral Crow's Feet Line areas.

Trial Locations (1)

Unknown

Beijing

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY